NASDAQ / LIVE COMPANY INTELLIGENCE

C4 Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCCCC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CCCC COVERAGE

What’s moving C4 Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know

C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know

The story matters when it changes C4 Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

The story matters when it changes C4 Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?

C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?

Investors are testing whether C4 Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates

Investors are testing whether C4 Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
C4 Therapeutics, Inc. (CCCC) Dips More Than Broader Markets: What You Should Know

C4 Therapeutics, Inc. (CCCC) Dips More Than Broader Markets: What You Should Know

The story matters when it changes C4 Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CCCC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-24 · Period 2026-06-24SEC ↗8-KMaterial company eventFiled 2026-06-11 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-05-15 · Period 2026-05-15SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-29 · Period 2026-04-29SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-27SEC ↗
EARNINGS / QUARTERLY TRACKER

C4 Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.